首页> 外文期刊>Investigative radiology >Macrophage Endocytosis of Superparamagnetic Iron Oxide Nanoparticles: Mechanisms and Comparison of Ferumoxides and Ferumoxtran-10.
【24h】

Macrophage Endocytosis of Superparamagnetic Iron Oxide Nanoparticles: Mechanisms and Comparison of Ferumoxides and Ferumoxtran-10.

机译:超顺磁性氧化铁纳米颗粒的巨噬细胞内吞作用:Ferumoxides和Ferumoxtran-10的机理与比较。

获取原文
获取原文并翻译 | 示例
           

摘要

SUMMARY: RATIONALE AND OBJECTIVES Superparamagnetic iron oxides (SPIO) used as magnetic resonance (MR) contrast agents undergo specific uptake by macrophages. The purpose of this study was first to determine the mechanism of macrophage uptake for Ferumoxides by using competition experiments with specific ligands of scavenger receptors SR-A (I/II) and second, to evaluate and compare the internalization of 2 different contrast agents, Ferumoxides (SPIO) and Ferumoxtran-10 (USPIO: ultrasmall superparamagnetic iron oxide) using macrophages obtained by chemical activation of human monocytic cells.METHODS Ferumoxides and Ferumoxtran-10 are 2 MR contrast agents, composed of dextran-coated iron oxide nanoparticles. The endocytosis pathway of Ferumoxides was studied using competition experiments on mouse peritoneal macrophages in the presence of specific ligands of scavenger receptors SR-A (types I and II): polyinosinic acid and fucoidan. In vitro assays using THP-1 (human promonocyte) cells activated into macrophages were performed in the presence of the 2 superparamagnetic nanoparticles. The cellular uptake was determined by measuring the iron content using ICP-AES (inductively coupled plasma-atomic emission spectrometry) and by Prussian blue staining.RESULTS In the presence of polyinosinic acid or fucoidan, the endocytosis of Ferumoxides by mouse peritoneal macrophages was inhibited. This inhibition was obtained using 10 microg/mL of scavenger receptor ligands at a concentration of 62.5 microg Fe/mL of SPIO, and a dose-dependent relationship was observed. Without competitors, the percentage of uptake of Ferumoxides by mouse peritoneal macrophages ranged between 3 and 8%. On the human activated monocyte THP-1 cell assay, Ferumoxides underwent a higher macrophage uptake (between 1.1 and 3%) compared with Ferumoxtran-10 (between 0.03 and 0.12%). This difference is attributed to the larger size of Ferumoxides nanoparticles.CONCLUSIONS Competition experiments indicate that the cellular uptake of Ferumoxides involves scavenger receptor SR-A-mediated endocytosis. The comparison between Ferumoxides and Ferumoxtran-10 confirms that macrophage uptake of iron oxide nanoparticles depends mainly on the size of these contrast agents.
机译:概述:理由和目标用作磁共振(MR)造影剂的超顺磁性氧化铁(SPIO)会被巨噬细胞特异性摄取。这项研究的目的首先是通过与清除剂受体SR-A(I / II)的特定配体进行竞争实验来确定巨噬细胞摄取Ferumoxides的机制,其次是评估和比较2种不同造影剂Ferumoxides的内在化(SPIO)和Ferumoxtran-10(USPIO:超小型超顺磁性氧化铁),其通过人类单核细胞的化学活化获得巨噬细胞。方法Ferumoxides和Ferumoxtran-10是2种MR造影剂,由葡聚糖包被的氧化铁纳米颗粒组成。在清除剂受体SR-A(I和II型)的特定配体:多肌苷酸和岩藻依聚糖的存在下,使用小鼠腹腔巨噬细胞的竞争实验研究了Ferumoxides的内吞途径。在2种超顺磁性纳米粒子的存在下,进行了使用活化为巨噬细胞的THP-1(人类原核细胞)细胞的体外测定。通过使用ICP-AES(电感耦合等离子体原子发射光谱法)和普鲁士蓝染色测量铁含量来测定细胞摄取。结果在存在多肌苷酸或岩藻依聚糖的情况下,抑制了小鼠腹膜巨噬细胞对阿魏酸的内吞作用。使用浓度为62.5微克Fe / mL SPIO的10微克/ mL清道夫受体配体获得了这种抑制作用,并观察到剂量依赖性。在没有竞争者的情况下,小鼠腹膜巨噬细胞摄取亚铁的百分比范围为3%至8%。在人类激活的单核细胞THP-1细胞测定中,与Ferumoxtran-10(介于0.03和0.12%之间)相比,Ferumoxides具有更高的巨噬细胞摄取(介于1.1和3%之间)。这一差异归因于阿魏酸纳米粒子的较大尺寸。结论竞争实验表明,阿魏酸的细胞摄取涉及清道夫受体SR-A介导的内吞作用。 Ferumoxides和Ferumoxtran-10之间的比较证实,巨噬细胞对氧化铁纳米颗粒的摄取主要取决于这些造影剂的大小。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号